Cargando…

Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System

Following peripheral nerve injury, dysregulations of certain non-coding microRNAs (miRNAs) occur in Schwann cells. Whether these alterations are the result of local inflammation and/or correlate with perturbations in the expression profile of the protective vasoactive intestinal peptide (VIP)/pituit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musumeci, Giuseppe, Leggio, Gian Marco, Marzagalli, Rubina, Al-Badri, Ghaith, Drago, Filippo, Castorina, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979605/ https://www.ncbi.nlm.nih.gov/pubmed/29587404 http://dx.doi.org/10.3390/ijms19040981

Ejemplares similares

Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
por: Lee, Jayden, et al.
Publicado: (2023)

Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)

Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
por: Broome, Sarah Thomas, et al.
Publicado: (2023)

PACAP Interacts with PAC(1) Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures
por: Castorina, Alessandro, et al.
Publicado: (2015)

Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet
por: Mandwie, Mawj, et al.
Publicado: (2021)

Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
por: Withana, Minduli, et al.
Publicado: (2023)

Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications
por: Marzagalli, Rubina, et al.
Publicado: (2015)

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022)

PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism
por: Vu, John P., et al.
Publicado: (2023)

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
por: Temerozo, Jairo R., et al.
Publicado: (2013)

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP
por: Liao, Chenyi, et al.
Publicado: (2021)

PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
por: Karunia, Jocelyn, et al.
Publicado: (2021)

Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
por: Giunta, Salvatore, et al.
Publicado: (2015)

Messenger RNA Gene Expression Screening of VIP and PACAP Neuropeptides and Their Endogenous Receptors in Ruminants
por: Hawley, Emma, et al.
Publicado: (2022)

Effects of PACAP on Schwann Cells: Focus on Nerve Injury
por: Maugeri, Grazia, et al.
Publicado: (2020)

Signal Transduction by VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2022)

Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
por: Jansen, Margo I., et al.
Publicado: (2022)

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP
por: Bensalma, Souheyla, et al.
Publicado: (2019)

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021)

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
por: Lu, Jessica, et al.
Publicado: (2022)

Female reproductive functions of the neuropeptide PACAP
por: Koppan, Miklos, et al.
Publicado: (2022)

Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?
por: Castorina, Alessandro, et al.
Publicado: (2015)

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression
por: Maugeri, Grazia, et al.
Publicado: (2016)

Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
por: Schytz, Henrik Winther, et al.
Publicado: (2010)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress
por: Cline, Daemon L., et al.
Publicado: (2018)

The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?
por: Marzagalli, Rubina, et al.
Publicado: (2015)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms
por: Ng, Stephanie Y. L., et al.
Publicado: (2012)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023)

Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration
por: Woodley, Patricia K., et al.
Publicado: (2019)

The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2022)

Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction
por: Yan, Xiang, et al.
Publicado: (2023)

Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock
por: Ono, Daisuke, et al.
Publicado: (2021)

Expression and significance of TIMP-3, PACAP and VIP in vaginal wall tissues of patients with stress urinary incontinence
por: Fan, Bo, et al.
Publicado: (2017)

Corrigendum: Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock
por: Ono, Daisuke, et al.
Publicado: (2021)

PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models*
por: Anapindi, Krishna D.B., et al.
Publicado: (2019)

Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP)
por: de Mendonça, Jeferson Cedaro, et al.
Publicado: (2015)

Interferon-γ Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability of Neural Progenitor Cells
por: Mäkelä, Johanna, et al.
Publicado: (2010)

Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat
por: Christiansen, Tove, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_f0u7kd1u8r9uuv8r0ah0idv76v